Real-world outcomes associated with vonoprazan-based versus proton pump inhibitor-based therapy for Helicobacter pylori infection in Japan

BACKGROUND: Japanese guidelines recommend triple therapy with vonoprazan or a proton pump inhibitor (PPI) in combination with antibiotics to treat Helicobacter pylori (H. pylori) infection. While studies have shown improved eradication rates and reduced costs with vonoprazan versus PPIs, there is li...

Descripción completa

Detalles Bibliográficos
Autores principales: Howden, Colin W., Cook, Erin E., Swallow, Elyse, Yang, Karen, Guo, Helen, Pelletier, Corey, Jacob, Rinu, Sugano, Kentaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Helicobacter pylori Infection — pathogenesis, management and prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161293/
https://www.ncbi.nlm.nih.gov/pubmed/37153499
http://dx.doi.org/10.1177/17562848231168714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161293/
https://www.ncbi.nlm.nih.gov/pubmed/37153499
http://dx.doi.org/10.1177/17562848231168714

Ejemplares similares